XML 8 R2.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Thousands
Mar. 31, 2025
Dec. 31, 2024
Current assets    
Cash and cash equivalents $ 8,639 $ 14,531
Accounts receivable, net of allowance for credit loss of $343 and $370, respectively 1,479 1,573
Prepaid expenses and other current assets 1,126 699
Total current assets 11,244 16,803
Property, equipment, and software, net 2,521 2,593
Restricted cash - long-term portion 242 241
Other assets 0 1
Total assets 14,007 19,638
Current liabilities    
Convertible promissory notes, net 25,747 29,376
Accounts payable 1,175 684
Accrued expenses and other current liabilities 2,102 3,098
Deferred revenue 1,604 1,518
Total current liabilities 30,628 34,676
Non-current liabilities    
Other long-term liabilities 62 71
Total non-current liabilities 62 71
Total liabilities 30,690 34,747
Commitments and contingencies (Note 10)
Stockholders' deficit    
Preferred stock: $0.0001 par value; 5,000,000 and 5,000,000 authorized; 0 and 0 issued and outstanding; aggregate liquidation preference of $0 and $0 at March 31, 2025 and December 31, 2024, respectively 0 0
Common stock: $0.0001 par value; 200,000,000 and 200,000,000 authorized; 3,282,858 and 3,229,575 issued at March 31, 2025 and December 31, 2024, respectively 0 0
Treasury stock: 154,055 and 154,055 shares held at March 31, 2025 and December 31, 2024, respectively (31,663) (31,663)
Additional paid-in capital 96,706 96,499
Accumulated deficit (81,726) (79,945)
Total stockholders' deficit (16,683) (15,109)
Total liabilities and stockholders' deficit $ 14,007 $ 19,638